13F HOLDINGS REPORT
Foresite Capital Management IV, LLC
Quarter ended Q3 2025 · Filed November 14, 2025 · Accession 0001104659-25-112500
Total Value
$182.6M
Positions
6
Other Managers
0
Confidential Omitted
No
Holdings (6)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Pharvaris N.V. | PHVS | 4,778,581 | $119.2M | 65.29% |
| 2 | CYTOKINETICS INC | CYTK | 458,295 | $25.2M | 13.79% |
| 3 | Maze Therapeutics, Inc. | MAZE | 522,657 | $13.6M | 7.42% |
| 4 | Lyell Immunopharma, Inc. | LYEL | 800,399 | $13.0M | 7.12% |
| 5 | Xenon Pharmaceuticals Inc. | XENE | 160,000 | $6.4M | 3.52% |
| 6 | Relay Therapeutics, Inc. | RLAY | 1,000,000 | $5.2M | 2.86% |